KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in TaxesDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Gsk (GSK) over the last 17 years, with Q4 2025 value amounting to -$54.5 million.

  • Gsk's Exchange Rate Effect fell 13631.32% to -$54.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$23.5 million, marking a year-over-year decrease of 13270.09%. This contributed to the annual value of -$25.1 million for FY2025, which is 6370.12% up from last year.
  • Per Gsk's latest filing, its Exchange Rate Effect stood at -$54.5 million for Q4 2025, which was down 13631.32% from $79.6 million recorded in Q3 2025.
  • Gsk's 5-year Exchange Rate Effect high stood at $687.6 million for Q4 2023, and its period low was -$1.8 billion during Q4 2022.
  • In the last 5 years, Gsk's Exchange Rate Effect had a median value of -$12.0 million in 2024 and averaged -$54.1 million.
  • Data for Gsk's Exchange Rate Effect shows a peak YoY increase of 629690.2% (in 2022) and a maximum YoY decrease of 381809.0% (in 2022) over the last 5 years.
  • Quarter analysis of 5 years shows Gsk's Exchange Rate Effect stood at -$45.8 million in 2021, then plummeted by 3818.09% to -$1.8 billion in 2022, then soared by 138.29% to $687.6 million in 2023, then plummeted by 78.16% to $150.2 million in 2024, then plummeted by 136.31% to -$54.5 million in 2025.
  • Its Exchange Rate Effect stands at -$54.5 million for Q4 2025, versus $79.6 million for Q3 2025 and -$34.7 million for Q2 2025.